Company profile: ShiraTronics
1.1 - Company Overview
Company description
- Provider of neuromodulation technology for chronic migraine, including a fully implantable Chronic Migraine Therapy System that delivers electrical pulses to nerve pathways in the head to relieve symptoms, and the RELIEV-CM clinical study evaluating its effectiveness in reducing headache frequency.
Products and services
- RELIEV-CM Clinical Study: A clinical research study evaluating the Chronic Migraine Therapy System’s effectiveness in reducing headache frequency among chronic migraine sufferers through neuromodulation-based therapy
- Chronic Migraine Therapy System: A fully implantable neuromodulation product that delivers electrical pulses to nerve pathways in the head, targeting chronic migraine treatment and relieving debilitating symptoms
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to ShiraTronics
Abide Therapeutics
HQ: United States
Website
- Description: Provider of pharmaceutical research and drug development focused on serine hydrolase inhibitors.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Abide Therapeutics company profile →
Dogwood Therapeutics
HQ: United States
Website
- Description: Provider of clinical-stage antiviral therapies targeting fibromyalgia and Long COVID, including IMC-1, a fixed-dose combination of famciclovir and celecoxib designed to suppress herpes virus replication and reduce fibromyalgia symptoms, and IMC-2, a combination of valacyclovir and celecoxib developed to manage Long COVID-related fatigue, sleep issues, and pain.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Dogwood Therapeutics company profile →
Heron Therapeutics
HQ: United States
Website
- Description: Provider of polymer-based pharmaceuticals for acute and oncology care, offering therapies to reduce postsurgical pain and prevent nausea and vomiting from chemotherapy and surgery. Products include SUSTOL (5-HT3 antagonist), CINVANTI (IV NK1 antagonist), ZYNRELEF (bupivacaine + meloxicam), and APONVIE (IV NK1 antagonist), plus Acute Care Solutions and Oncology Care Solutions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Heron Therapeutics company profile →
Myoscience
HQ: United States
Website
- Description: Provider of technology-driven dermatological products, focusing on their development and commercialization; founded in 2005 and headquartered in Redwood City, California.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Myoscience company profile →
Flexion Therapeutics
HQ: United States
Website
- Description: Provider of long-lasting intra-articular injection therapies to treat osteoarthritis, and of collaborative drug development services that advance candidates through clinical proof of concept and beyond in partnership with pharmaceutical and biotechnology companies, sharing expertise and risk to help expand partners' portfolios.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Flexion Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for ShiraTronics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to ShiraTronics
2.2 - Growth funds investing in similar companies to ShiraTronics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for ShiraTronics
4.2 - Public trading comparable groups for ShiraTronics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →